Key result
Elevated T-wave heterogeneity predicts ~28-fold higher short-term cardiac mortality in women with ACS.
Why the study?
It was unknown whether T-wave heterogeneity can identify patients at risk for near-term cardiac mortality.
Does elevated T-wave heterogeneity (TWH) on a resting 12-lead ECG predict 90-day cardiac mortality in patients evaluated for acute coronary syndrome?
Case-Control (n=100)
Blinded to clinical outcomes
No
Does elevated T-wave heterogeneity (TWH) on a resting 12-lead ECG predict 90-day cardiac mortality in patients evaluated for acute coronary syndrome?
Effect estimate: HR 27.84 (95% CI 7.29-106.36)
p-value: p=<0.0001
Elevated T-wave heterogeneity in leads V4-6 on a standard resting 12-lead ECG strongly predicts 90-day cardiac mortality in women evaluated for acute coronary syndrome in the emergency department.
Elevated TWH may flag high near-term mortality risk in women with suspected ACS; leaves open prospective validation before clinical use.
Background We investigated whether T‐wave heterogeneity (TWH) can identify patients who are at risk for near‐term cardiac mortality. Methods A nested case–control analysis was performed in the 888 patients admitted to the Emergency Department (ED) of our medical center in July through September 2018 who had ≥2 serial troponin measurement tests within 6 hr for acute coronary syndrome evaluation to rule‐in or rule‐out the presence of acute myocardial infarction. Patients who died from cardiac causes during 90 days after ED admission were considered cases ( n = 20; 10 women) and were matched 1:4 on sex and age with patients who survived during this period ( n = 80, 40 women). TWH, that is, interlead splay of T waves, was automatically assessed from precordial leads by second central moment analysis. Results TWH V4‐6 was significantly elevated at ED admission in 12‐lead resting ECGs of female patients who died of cardiac causes during the following 90 days compared to female survivors (100 ± 14.9 vs. 40 ± 3.6 µV, p < .0001). TWH V4‐6 generated areas under the receiver‐operating characteristic (ROC) curve (AUC) of 0.933 in women ( p < .0001) and 0.573 in men ( p = .4). In women, the ROC‐guided 48‐µV TWH V4‐6 cut point for near‐term cardiac mortality produced an adjusted odds ratio of 121.37 (95% CI: 2.89–6,699.84; p = .02) with 100% sensitivity and 82.5% specificity. In Kaplan–Meier survival analysis, TWH V4‐6 ≥ 48 µV predicted cardiac mortality in women during 90‐day follow‐up with a hazard ratio of 27.84 (95% CI: 7.29–106.36, p < .0001). Conclusion Elevated TWH V4‐6 is associated with near‐term cardiac mortality among women evaluated for acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Monteiro et al. (2021) conducted a case-control in Acute coronary syndrome evaluation (n=100). Elevated T-wave heterogeneity (TWHV4-6 ≥ 48 µV) vs. TWHV4-6 < 48 µV was evaluated on 90-day cardiac mortality in women (HR 27.84, 95% CI 7.29-106.36, p=<0.0001). Elevated T-wave heterogeneity (≥48 µV in leads V4-V6) significantly predicted 90-day cardiac mortality in women evaluated for acute coronary syndrome (HR 27.84).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: